No profile data available.
Biotricity, Inc. (BTCY) is a healthcare company in the heart treatment equipment industry, based in Redwood City, United States, with about 46 full-time employees.
It reported revenue of $13.79 million for fiscal year 2025, up 14.3% from fiscal year 2024, and net income of -$11.94 million. In Q3 2026 (the quarter ended December 31, 2025) revenue was $3.99 million, up 10.2% from a year before. Its largest business segment, Technology Fees, brought in 90% of segment revenue in fiscal year 2026. Its market capitalization was $1.06 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
Biotricity reported $13.79 million in revenue for fiscal year 2025, up 14.3% from $12.06 million in fiscal year 2024. In Q3 2026 revenue was $3.99 million.
Technology Fees, with $14.44 million or 90% of segment revenue in fiscal year 2026. Next: Device Sales (10%).
$1.06 million as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Cardiac Biotech Solutions Inc. (CBSC), Adagio Medical Holdings, Inc. (ADGM), Nuwellis, Inc. (NUWE), Catheter Precision, Inc. (VTAK).